| Efficacy and safety of peppermint oil in a randomized, double-blind trial of patients with irritable bowel syndrome ZZRM Weerts, AAM Masclee, BJM Witteman, CHM Clemens, B Winkens, ... Gastroenterology 158 (1), 123-136, 2020 | 110 | 2020 |
| Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study L Vork, ZZRM Weerts, Z Mujagic, JW Kruimel, MAM Hesselink, JWM Muris, ... Neurogastroenterology & Motility 30 (2), e13189, 2018 | 104 | 2018 |
| Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome ZZRM Weerts, L Vork, Z Mujagic, D Keszthelyi, MAM Hesselink, J Kruimel, ... Neurogastroenterology & Motility 31 (8), e13629, 2019 | 44 | 2019 |
| transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome AB Beckers, Z Weerts, Z Helyes, AAM Masclee, D Keszthelyi Alimentary Pharmacology & Therapeutics 46 (10), 938-952, 2017 | 42 | 2017 |
| Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome Z Mujagic, D Jonkers, S Ludidi, D Keszthelyi, MA Hesselink, Z Weerts, ... Neurogastroenterology & Motility 29 (12), e13137, 2017 | 41 | 2017 |
| Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome JTW Snijkers, W Van Den Oever, ZZRM Weerts, L Vork, Z Mujagic, ... Neurogastroenterology & Motility 33 (12), e14161, 2021 | 35 | 2021 |
| Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome Z Mujagic, M Kasapi, DMAE Jonkers, I Garcia-Perez, L Vork, ... Gut Microbes 14 (1), 2063016, 2022 | 31 | 2022 |
| A novel ileocolonic release peppermint oil capsule for treatment of irritable bowel syndrome: a Phase I study in healthy volunteers ZZRM Weerts, D Keszthelyi, L Vork, NCP Aendekerk, HW Frijlink, ... Advances in therapy 35, 1965-1978, 2018 | 17 | 2018 |
| A putative anti‐inflammatory role for TRPM8 in irritable bowel syndrome—An exploratory study M Peiris, ZZRM Weerts, R Aktar, AAM Masclee, A Blackshaw, ... Neurogastroenterology & Motility 33 (9), e14170, 2021 | 15 | 2021 |
| Does day-to-day variability in stool consistency link to the fecal microbiota composition? L Vork, J Penders, J Jalanka, S Bojic, SMJ van Kuijk, A Salonen, ... Frontiers in cellular and infection microbiology 11, 639667, 2021 | 12 | 2021 |
| Age-related decrease in abdominal pain and associated structural-and functional mechanisms: an exploratory study in healthy individuals and irritable bowel syndrome patients AB Beckers, E Wilms, Z Mujagic, B Kajtár, K Csekő, ZZRM Weerts, L Vork, ... Frontiers in Pharmacology 12, 806002, 2021 | 11 | 2021 |
| The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect health care costs MHMA Bosman, ZZRM Weerts, JTW Snijkers, L Vork, Z Mujagic, ... Clinical Gastroenterology and Hepatology 21 (10), 2660-2669, 2023 | 10 | 2023 |
| A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome ZZRM Weerts, BAB Essers, DMAE Jonkers, JIA Willems, DJPA Janssen, ... UEG Journal 9 (9), 997-1006, 2021 | 10 | 2021 |
| Effect of obesity on the expression of nutrient receptors and satiety hormones in the human colon L Baumard, ZZRM Weerts, AAM Masclee, D Keszthelyi, AT Michael-Titus, ... Nutrients 13 (4), 1271, 2021 | 9 | 2021 |
| Smart data collection for the assessment of treatment effects in irritable bowel syndrome: observational study ZZRM Weerts, KGE Heinen, AAM Masclee, ABA Quanjel, B Winkens, ... JMIR mHealth and uHealth 8 (11), e19696, 2020 | 8 | 2020 |
| Evidence for engagement of the nucleus of the solitary tract in processing intestinal chemonociceptive input irrespective of conscious pain response in healthy humans AB Beckers, L van Oudenhove, ZZRM Weerts, HIL Jacobs, N Priovoulos, ... Pain 163 (8), 1520-1529, 2022 | 7 | 2022 |
| The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome R Sturkenboom, D Keszthelyi, L Brandts, ZZRM Weerts, JTW Snijkers, ... Quality of Life Research, 1-13, 2022 | 5 | 2022 |
| Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method AB Beckers, JTW Snijkers, ZZRM Weerts, L Vork, T Klaassen, ... JMIR Formative Research 5 (11), e31678, 2021 | 3 | 2021 |
| Satisfaction with life in IBS is associated with psychological burden rather than gastrointestinal symptom severity JTW Snijkers, B Winkens, ZZRM Weerts, L Vork, Z Mujagic, ... The American Journal of Gastroenterology 119 (3), 512, 2024 | 2 | 2024 |
| Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study ZZRM Weerts, KGE Heinen, AAM Masclee, ABA Quanjel, B Winkens, ... JMIR mHealth and uHealth 9 (2), 2021 | 2 | 2021 |
Daniel KeszthelyiMaastricht University Medical CenterVerified email at maastrichtuniversity.nl
